Literature DB >> 2510616

Fetal loss treatment in patients with antiphospholipid antibodies.

J Ordi1, J Barquinero, M Vilardell, R Jordana, C Tolosa, A Selva, E Genover.   

Abstract

A group of seven young women with antiphospholipid antibodies, histories of recurrent fetal loss, and no live births is reported. Two patients had systemic lupus erythematosus, and the other five fulfilled criteria for the primary antiphospholipid syndrome. A false Venereal Disease Research Laboratory (VDRL) test was present in four of the patients, three had a previous episode of arterial or venous thrombosis, or both, and two had thrombocytopenia. Prednisone and acetylsalicylic acid were given, and monthly controls of lupus anticoagulant activity were carried out. The dose of acetylsalicylic acid was fixed while the dose of steroids was adjusted according to the degree of lupus anticoagulant activity. A fetal survival was obtained in 7/9 (78%) of the pregnancies. Three of the newborn infants had transitory lupus anticoagulant activity. A search for antiphospholipid antibodies should be carried out in patients with otherwise unexplained fetal losses, falsely positive VDRL tests, thrombosis, or thrombocytopenia as the treatment of such patients with prednisone and acetylsalicylic acid is highly effective.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2510616      PMCID: PMC1003884          DOI: 10.1136/ard.48.10.798

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  21 in total

1.  Lupus anticoagulant and pregnancy management.

Authors:  R G Farquharson; J F Pearson; L John
Journal:  Lancet       Date:  1984-07-28       Impact factor: 79.321

2.  Possible relationship between lupus inhibitor and recurrent abortion in young women.

Authors:  B G Firkin; M A Howard; N Radford
Journal:  Lancet       Date:  1980-08-16       Impact factor: 79.321

3.  Extremely-low-dose aspirin (1 mg per day) renders human platelets more sensitive to antiaggregation prostaglandins.

Authors:  H Sinzinger; J O'Grady; P Fitscha; J Kaliman
Journal:  N Engl J Med       Date:  1984-10-18       Impact factor: 91.245

4.  Prekallikrein inhibition associated with the lupus anticoagulant: a mechanism of thrombosis.

Authors:  M J Sanfelippo; C J Drayna
Journal:  Am J Clin Pathol       Date:  1982-03       Impact factor: 2.493

5.  Intrauterine death and circulating anticoagulant ("antithromboplastin").

Authors:  I M Nilsson; B Astedt; U Hedner; D Berezin
Journal:  Acta Med Scand       Date:  1975-03

6.  Lupus anticoagulant in pregnancy.

Authors:  W F Lubbe; W S Butler; S J Palmer; G C Liggins
Journal:  Br J Obstet Gynaecol       Date:  1984-04

7.  The 1982 revised criteria for the classification of systemic lupus erythematosus.

Authors:  E M Tan; A S Cohen; J F Fries; A T Masi; D J McShane; N F Rothfield; J G Schaller; N Talal; R J Winchester
Journal:  Arthritis Rheum       Date:  1982-11

8.  Thrombosis in systemic lupus erythematosus: striking association with the presence of circulating lupus anticoagulant.

Authors:  M L Boey; C B Colaco; A E Gharavi; K B Elkon; S Loizou; G R Hughes
Journal:  Br Med J (Clin Res Ed)       Date:  1983-10-08

9.  Thromboembolism in patients with the 'lupus'-type circulating anticoagulant.

Authors:  M Elias; A Eldor
Journal:  Arch Intern Med       Date:  1984-03

10.  Monoclonal immunoglobulin M lambda coagulation inhibitor with phospholipid specificity. Mechanism of a lupus anticoagulant.

Authors:  P Thiagarajan; S S Shapiro; L De Marco
Journal:  J Clin Invest       Date:  1980-09       Impact factor: 14.808

View more
  4 in total

Review 1.  Pregnancy and antibodies to phospholipids.

Authors:  M J Walport
Journal:  Ann Rheum Dis       Date:  1989-10       Impact factor: 19.103

2.  Induction of anti-phospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anti-cardiolipin antibodies.

Authors:  M Blank; J Cohen; V Toder; Y Shoenfeld
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

Review 3.  The 'antiphospholipid syndrome' and the 'lupus anticoagulant'.

Authors:  J S Cameron; G Frampton
Journal:  Pediatr Nephrol       Date:  1990-11       Impact factor: 3.714

4.  Glucocorticoids Improve the Pregnancy Rate and Outcome in Women With Unexplained Positive Autoantibodies: A Systematic Review and Meta-Analysis.

Authors:  Ting Li; Yilin Yuan; Huixin Liu; Qun Lu; Rong Mu
Journal:  Front Med (Lausanne)       Date:  2022-05-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.